Prime Medicine Inc. (PRME)
NASDAQ · Healthcare
Prime Medicine Inc. Shareholder Equity 2020–2025
Prime Medicine Inc. annual/quarterly shareholder equity history from 2021 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Prime Medicine Inc. shareholder equity for the quarter ending December 31, 2025 were 120.9M, a 21.08% decrease year-over-year.
- Prime Medicine Inc. shareholder equity for 2025 were 120.9M, a 21.08% decrease from 2024.
- Prime Medicine Inc. shareholder equity for 2024 were 153.1M, a 15.09% increase from 2023.
- Prime Medicine Inc. shareholder equity for 2023 were 133.1M, a 57.92% decrease from 2022.
- Prime Medicine Inc. shareholder equity for 2022 were 316.3M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Prime Medicine Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $121 |
| 2024 | $153 |
| 2023 | $133 |
| 2022 | $316 |
| 2021 | $-156 |
| Prime Medicine Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $121 |
| 2024-12-31 | $153 |
| 2023-12-31 | $133 |
| 2022-12-31 | $316 |
| 2021-12-31 | $-156 |
Prime Medicine Inc. Shareholder Equity — FAQ
Prime Medicine Inc. (PRME) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PRME's shareholder equity history?
The chart and table above show Prime Medicine Inc.'s shareholder equity by year and by quarter, including the growth rate.